Ignite Creation Date:
2024-05-06 @ 1:43 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04101474
Status:
UNKNOWN
Last Update Posted:
2019-09-27
First Post:
2019-09-22
Brief Title:
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
Status:
UNKNOWN
Status Verified Date:
2019-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior ideation and thoughts in patients with treatment- resistant MDD
Detailed Description:
A Twice repetition of IV infusion of 05 mgkg of ketamine produces an antidepressant response in individuals with treatment-resistant MDD
The work aims to
1 To assess the onset of action and degree of improvement and the duration of antidepressant effect of ketamine in a sample of patients with treatment -resistant major depressive disorder
2 To find out whether the onset of Ketamine antidepressant effect is associated with an improvement of suicidality in those patients
The work aims to
1 To assess the onset of action and degree of improvement and the duration of antidepressant effect of ketamine in a sample of patients with treatment -resistant major depressive disorder
2 To find out whether the onset of Ketamine antidepressant effect is associated with an improvement of suicidality in those patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None